Munafa AJANTPHARM (target) price & Options chain analysis (Ajanta Pharma Limited) Option chain analysis (AJANTPHARM) 27 Sat April Expiry
Munafa AJANTPHARM (target) price & Options chain analysis (Ajanta Pharma Limited) Option chain analysis (AJANTPHARM) 27 Sat April Expiry Which Call CE or PUT PE options to buy or sell in Ajanta Pharma Limited AJANTPHARM
AJANTPHARM Most Active Call Put OptionsAJANTPHARM SPOT Price: 2193.50 as on 26 Apr, 2024
Ajanta Pharma Limited (AJANTPHARM) target & price
AJANTPHARM Target | Price |
Target up: | 2367.1 |
Target up: | 2323.7 |
Target up: | 2280.3 |
Target up: | 2200.15 |
Target down: | 2156.75 |
Target down: | 2113.35 |
Target down: | 2033.2 |
Date | Close | Open | High | Low | Volume |
26 Fri Apr 2024 | 2193.50 | 2144.00 | 2286.95 | 2120.00 | 0.21 M |
25 Thu Apr 2024 | 2139.95 | 2130.80 | 2144.35 | 2125.05 | 0.04 M |
24 Wed Apr 2024 | 2133.70 | 2150.00 | 2169.20 | 2127.10 | 0.07 M |
23 Tue Apr 2024 | 2130.35 | 2100.00 | 2189.25 | 2090.45 | 0.1 M |
22 Mon Apr 2024 | 2091.35 | 2085.45 | 2125.00 | 2079.95 | 0.14 M |
19 Fri Apr 2024 | 2085.40 | 2078.85 | 2107.95 | 2069.15 | 0.03 M |
18 Thu Apr 2024 | 2078.85 | 2064.40 | 2098.95 | 2055.50 | 0.06 M |
16 Tue Apr 2024 | 2064.95 | 2098.50 | 2113.55 | 2051.60 | 0.05 M |
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
AJANTPHARM Option Chain Data Analysis for Ajanta Pharma Limited AJANTPHARM option chain
Maximum Call writing has been for strikes:
Until yesterday Maximum Call writing has been for strikes:
Open Interest of Call writers for the options of Ajanta Pharma Limited AJANTPHARM is shifting downwards. This would mean that markets are slowly moving downwards, and buying CALLS and CE might not be profitable.
Maximum Put writing has been for strikes:
Until yesterday Maximum Put writing has been for strikes:
Open Interest of PUT writers for the options of Ajanta Pharma Limited AJANTPHARM is shifting downwards. This would mean that markets are slowly moving downwards, and buying PUTS and PE might be more profitable. However, above mentioned levels will serve as support so avoid buying PE below those above mentioned levels.
AJANTPHARM Option Chain Price Analysis for Ajanta Pharma Limited AJANTPHARM option chain
Stock is in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Ajanta Pharma Limited AJANTPHARM at this time.
It appears as if Ajanta Pharma Limited AJANTPHARM gave a large move recently.
Stock of Ajanta Pharma Limited (AJANTPHARM) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Ajanta Pharma Limited is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 2214 as stoploss in an intra day sell trade for a target of 2155.85. However, stock will show a bullish move above 2214.
Ajanta Pharma Limited AJANTPHARM Option Chain, OTM CE, ITM PE
Below is full option chain of Ajanta Pharma Limited for strikes which are OTM CALLS (CE), and ITM PUTS (PE).
These are CALLS which have only time value in them, no intrinsic value. PUTS however have both time value and intrinsic value in the premium.
Ajanta Pharma Limited AJANTPHARM Option Chain, ITM CE, OTM PE
Below is full option chain of Ajanta Pharma Limited for strikes which are ITM CALLS (CE), and OTM PUTS (PE).
These are PUTS which have only time value in them, no intrinsic value. CALLS however have both time value and intrinsic value in the premium.
Videos related to: Munafa AJANTPHARM (target) price & Options chain analysis (Ajanta Pharma Limited) Option chain analysis (AJANTPHARM) 27 Sat April Expiry
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance